US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.78

+0.07500.20%

Post-market: 36.75-0.0250-0.07%16:53 EDT

Volume:177.68K

Turnover:6.54M

Market Cap:849.13M

PE:- -

High:37.05

Open:36.69

Low:36.66

Close:36.70

52wk High:38.19

52wk Low:28.26

Shares:23.09M

Float Shares:23.09M

Volume Ratio:1.91

T/O Rate:0.77%

Dividend:0.23

Dividend Rate:0.63%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

Cambium Bio Plans New Share Placement to Bolster Capital Base

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits

Barclays downgrades Scholar Rock on valuation after FDA approval

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine

Prescient Therapeutics Extends Securities Purchase Plan Deadline

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says

MT Newswires Live

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Long-Term Bribery Involving 30+ Pharmaceutical Firms Prompts Hospital Response

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/RSPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.775,"timestamp":1789588800000,"preClose":36.7,"halted":0,"volume":177676,"hourTrading":{"tag":"盘后","latestPrice":36.75,"preClose":36.775,"latestTime":"16:53 EDT","volume":11,"amount":404.48003200000005,"timestamp":1789592037403,"change":-0.025,"changeRate":-0.00068,"amplitude":0.001088},"delay":0,"changeRate":0.002043596730245115,"floatShares":23090000,"shares":23090000,"eps":0,"marketStatus":"Post-Mkt","change":0.075,"latestTime":"09-16 18:38:44 EDT","open":36.69,"high":37.05,"low":36.66,"amount":6543460.611799999,"amplitude":0.010627,"askPrice":36.8,"askSize":10,"bidPrice":33.61,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":36.7,"sharesOutstanding":23410000,"nav":36.59599,"aum":847197168.5,"dividendRate":0.006279,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.8,"preClose":36.7,"latestTime":"07:00 EDT","volume":25,"amount":919.9999999999999,"timestamp":1789556416033,"change":0.1,"changeRate":0.002725,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.75,"preClose":36.775,"latestTime":"16:53 EDT","volume":11,"amount":404.48003200000005,"timestamp":1789592037403,"change":-0.025,"changeRate":-0.00068,"amplitude":0.001088},"volumeRatio":1.90581,"impliedVol":0.0046,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23090000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.90581,"shares":23090000,"dividePrice":0.2309,"high":37.05,"amplitude":0.010627,"preClose":36.7,"low":36.66,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.775,"committee":0.818182,"eps":0,"divideRate":0.006279,"volume":177676,"delay":0,"ttmEps":0,"open":36.69,"prevYearClose":31.85,"prevWeekClose":36.08,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.3,"twentyDayClose":36,"sixtyDayClose":31.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668933761","title":"Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933761?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:03","pubTimestamp":1789588997,"startTime":"0","endTime":"0","summary":"Affinor Growers ( ($TSE:AFI) ) has issued an update. Affinor Growers has appointed biotechnology and sustainable agriculture innovator Dr. Hyder Kh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","IVEG","PJBF","SYNB","XT","FHLC","SDGS","JDOC","FWD","AGNG","FTAG","KROP","IEIH","RSPH","IBB","BK4588","BBP","BK4585","SDG","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133238050","title":"Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1133238050","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133238050?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:43","pubTimestamp":1789544611,"startTime":"0","endTime":"0","summary":"In 2026, the Ulanqab Municipal Market Regulation Bureau in Inner Mongolia has closely aligned with the regional sampling work deployment, making steady progress in its medical device quality control...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","GDOC","AGNG","BK1574","159883","LNGR","09996","MEDX","LGHT","RSPH","PTH","HART","BK1583","MDEV","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679025","title":"Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679025?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:57","pubTimestamp":1789527450,"startTime":"0","endTime":"0","summary":"The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical Limited, an ASX-listed biotechnology company, has reported changes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","XT","IBB","AGNG","SYNB","DARP","IEIH","FWD","RSPH","BK4585","BBP","BK4588","FHLC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676156","title":"Cambium Bio Plans New Share Placement to Bolster Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676156?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:52","pubTimestamp":1789523532,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regeneus Ltd. ( ($AU:CMB) ). Cambium Bio Limited, trading on the ASX under the ticker CMB, is a biotechnology c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","BK4588","SYNB","BBP","IBB","DARP","BK4585","AGNG","FHLC","XT","FWD","LNGR","RSPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["BK4585","IDNA","MEDI","GNMX","TECB","XLVX","FRTY","TBXU","LABU","XBIX","IBB","RSPH","GDOC","IYH","MRNY","PSCH","SYNB","BMED","PINK","BK4588","NVIB","BBP","LFSC","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140666287","title":"Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1140666287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140666287?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:06","pubTimestamp":1789473999,"startTime":"0","endTime":"0","summary":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IEIH","BK1583","PCR","RSPH","HART","MDEV","09996","LGHT","688426","AGNG","159883","BK1100","BK0239","BK1574","LNGR","MEDX","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178547175","title":"Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=1178547175","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178547175?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:24","pubTimestamp":1789471463,"startTime":"0","endTime":"0","summary":"Shanghai Kehua Bio-Engineering Co., Ltd. (SZSE: 002022) has announced that it, along with its controlled subsidiary Suzhou Tianlong Biotechnology Co., Ltd., has received medical device registration...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK1574","LNGR","159883","HART","BK0028","AGNG","GDOC","002022","LGHT","BK1583","09996","MEDX","RSPH","IEIH","PTH","BK1100","BK0188","BK0239","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSPA","BBP","TACU","MRNY","IEIH","IYH","BMED","TECB","IDNA","XLVX","LABU","PINK","LFSC","NVIB","MEDI","CDIG","PSCH","GDOC","GNMX","RSPH","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661509","title":"Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661509","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661509?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:47","pubTimestamp":1789447668,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, develops medical therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IEIH","RSPH","DARP","SYNB","LNGR","BK4585","BK4588","FHLC","BBP","XT","JDOC","AGNG","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124014323","title":"Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1124014323","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124014323?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:16","pubTimestamp":1789438610,"startTime":"0","endTime":"0","summary":"According to a research report released by Zheshang Securities Co.,Ltd., the external environment and internal growth drivers across medical device sub-sectors are expected to diverge in the second...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","MEDX","BK0276","GDOC","BK1583","HART","IEIH","159883","09996","BK1100","BK1574","MDEV","LNGR","601878","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667316690","title":"Prescient Therapeutics Extends Securities Purchase Plan Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667316690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667316690?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:02","pubTimestamp":1789437732,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) just unveiled an update. Prescient Therapeutics Limited, an ASX-listed biotechnology company trading u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FHLC","SYNB","BK4007","LENZ","DARP","BBP","IEIH","XT","BK4585","BK4539","IBB","JDOC","BK4588","LNGR","FWD","AGNG","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694618","title":"Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667694618?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:16","pubTimestamp":1789431375,"startTime":"0","endTime":"0","summary":"Syntara Limited ( ($AU:SNT) ) has provided an update. Syntara Limited, an ASX-listed clinical-stage biotechnology company based in Sydney, develops...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","AGNG","DARP","IBB","BBC","IEIH","RSPH","FWD","JDOC","SYNB","XT","BK4588","LNGR","BK4585","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","FHLC","HTEC","BK4585","AGNG","DARP","GNMX","JDOC","BBP","IBB","RSPH","BMED","HELX","SYNB","FWD","LNGR","BK4588","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664069","title":"Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664069","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664069?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:59","pubTimestamp":1789397969,"startTime":"0","endTime":"0","summary":"Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential benefits from industry consolidation, although slowing state reimbursement rates could constrain gr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADUS","RSPH","BK4196","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","MRNY","IEIH","LABU","GNMX","TECB","IYH","GDOC","BK4007","PSCH","PINK","SYNB","BFRI","NVIB","LFSC","BMED","TBXU","IDNA","BK4585","BBP","MRNX","XLVX","RSPH","BK4588","FRTY","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","MRNY","LFSC","LABU","PSCH","NVIB","IEIH","MRNX","XLVX","BBP","BK4585","GNMX","PINK","GDOC","SYNB","IBB","RSPH","IDNA","TBXU","TECB","IYH","BK4588","MEDI","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","SYNB","BK4588","AGNG","LNGR","BBP","RSPH","FHLC","FWD","XT","JDOC","IBB","CABA","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","SRRK","LFSC","GDOC","GNMX","IBRN","XLVX","FRTY","IDNA","LABU","MEDI","BK4139","THNR","NVIB","MRNX","TBXU","BK4585","IYH","PINK","SYNB","RSPH","BMED","BBP","MRNY","PSCH","IEIH","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122259450","title":"Long-Term Bribery Involving 30+ Pharmaceutical Firms Prompts Hospital Response","url":"https://stock-news.laohu8.com/highlight/detail?id=1122259450","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122259450?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:21","pubTimestamp":1789359679,"startTime":"0","endTime":"0","summary":"On September 13, China's National Healthcare Security Administration released a report detailing commercial bribery cases in medical institutions' pharmaceutical procurement. The report revealed that...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","MDEV","AGNG","IEIH","PTH","RSPH","09996","BK1100","GDOC","HART","LNGR","BK1583","BK1574","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","MRNY","IEIH","IYH","BMED","TECB","BK4179","BK4585","IDNA","MRNX","XLVX","LABU","PINK","LFSC","NVIB","TLX","MEDI","PSCH","GDOC","GNMX","RSPH","FET","BK4139","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}